Activation of the NF-κB/NLRP3 axis by USP38 accelerates adverse atrial remodeling under hemodynamic stress, suggesting USP38 as a potential therapeutic target for pressure-overload-induced AF. This evidence concerns the gene NLRP3 and atrial fibrillation.